Cellectis S.A.CLLSNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q3 2025 | 8.30% |
| Q2 2025 | -1.89% |
| Q1 2025 | 149.79% |
| Q4 2024 | -53.56% |
| Q3 2024 | -14.46% |
| Q2 2024 | -0.76% |
| Q1 2024 | -49.28% |
| Q4 2023 | 44.75% |
| Q3 2023 | -18.30% |
| Q2 2023 | 39.97% |
| Q1 2023 | 135.99% |
| Q4 2022 | -259.87% |
| Q3 2022 | 1.51% |
| Q2 2022 | -20.32% |
| Q1 2022 | -39.22% |
| Q4 2021 | 3.11% |
| Q3 2021 | 3.55% |
| Q2 2021 | 6.42% |
| Q1 2021 | -29.41% |
| Q4 2020 | 20.71% |
| Q3 2020 | 13.58% |
| Q2 2020 | -25.33% |
| Q1 2020 | 38.87% |
| Q4 2019 | -20.25% |
| Q3 2019 | -7.20% |
| Q2 2019 | 2.88% |
| Q1 2019 | 9.22% |
| Q4 2018 | -9.04% |
| Q3 2018 | 2.79% |
| Q2 2018 | -19.73% |
| Q1 2018 | 7.85% |
| Q4 2017 | 6.91% |
| Q3 2017 | 16.67% |
| Q2 2017 | 6.60% |
| Q1 2017 | -18.45% |
| Q4 2016 | 22.58% |
| Q3 2016 | 2.20% |
| Q2 2016 | -19.85% |
| Q1 2016 | 34.86% |
| Q4 2015 | -18.10% |